WHO ICTRP trial
preventing chemotherapy induced nausea and vomiting in children without using…
CTRI/2022/05/042750 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/05/042750 |
|---|---|
| Public title | preventing chemotherapy induced nausea and vomiting in children without using steroid (dexamethasone) |
| Scientific title | Anti-emetic prophylaxis for chemotherapy-induced nausea and vomiting without dexamethasone for children receiving highly emetogenic chemotherapy: investigator-initiated, open-label, phase 3 randomized controlled trial. |
| Primary sponsor | Cancer Institute |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: C00-D49- Neoplasms |
| Interventions | Intervention1: Arm B (OPF regimen): Experimental arm: Day 1: 1. Fosaprepitant ââ?¬Â¢ 12-18 years: 150 mg IV over 30 minutes. ââ?¬Â¢ 2 years to less than 12 years: 4 mg/kg (maximum dose 150 mg) intravenously over 60 minutes. ââ?¬Â¢ 6… |
| Registration date | May 23, 2022 |
| Target size | 360 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: